MentionFox
Home › funding signals › Aevumed Inc.
Form D · on the record

Aevumed Inc. — $264K Form D filing, June 2025

Aevumed Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-12.

Aevumed Inc. filed a Form D notice of an exempt securities offering with the SEC on June 12, 2025. The filing reports $264K sold. Its industry group is Biotechnology. It names SAIF KHALIL (Executive Officer, Director) (SEC Form D, June 12, 2025).

5 more Biotechnology raises in Pennsylvania within 90 days ↓

Is this your company?

Key facts

Run the free check on Aevumed Inc. →

Sell to companies like Aevumed Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Aevumed Inc.

New Form D on file · 2025-06-12 · the record

$264K
raise on the record
D
filing
10
investors in
PENNSYLVANIA
based
Open the record →

What the record says

FilingForm D
Filed2025-06-12
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedMALVERN, PENNSYLVANIA
CIK2065988
Accession0002065988-25-000002

Pitching, partnering or investing alongside them? See who really runs and owns Aevumed Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Aevumed Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.

What do you want to do with Aevumed Inc.?

Get the full cited report on Aevumed Inc.

What the filing shows about Aevumed Inc.

  • 10 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Aevumed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Aevumed Inc.'s address as 109 Great Valley Parkway, Malvern, PA 19355.

What the filing says

  • Offered: $264,000. Sold: $264,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 10 had already invested. (filing)
  • Date of first sale: April 19, 2018. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Aevumed Inc. See pricing

Is Aevumed Inc. a real, registered company?

Aevumed Inc. is a registered filer with the SEC (CIK 2065988) and has filed since 2025-06-12. 4 filings are on record, the latest on 2025-06-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Aevumed Inc.?

Aevumed Inc.'s Form D of 2025-06-12 names SAIF KHALIL as its officers, directors or promoters.

How much has Aevumed Inc. raised?

Its new offerings report $5.07M sold across 4 offerings, as its own filings state.

Filing history · 4 filings on this registrant
Form D · 2025-06-12 · $264K · this pageForm D · 2025-06-12 · $1.50MForm D · 2025-06-12 · $3MForm D · 2025-06-12 · $305K 2025-06-12 2025-06-12

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 769 filings in Biotechnology, totalled by week.

Want the whole picture on Aevumed Inc.?

What the filing shows about Aevumed Inc.

  • 10 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Aevumed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Aevumed Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Aevumed Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Aevumed Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Aevumed Inc.: Raised $264K, Form D filed 2025-06-12
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/aevumed-inc-form-d-25000001
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
Aevumed Inc. raised $264K — SEC Form D filing, June 2025. MentionFox, 2026-11-01. https://mentionfox.com/funding/aevumed-inc-form-d-25000001